{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:41:02Z","timestamp":1792424462838,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04509-x","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:32:47Z","timestamp":1784770367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An individualized nomogram for survival prediction in intrahepatic cholangiocarcinoma: a population-based analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Hui","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4847-6820","authenticated-orcid":false,"given":"Xiangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingguang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"6","key":"4509_CR1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.surg.2012.12.005","volume":"153","author":"O Hyder","year":"2013","unstructured":"Hyder O, Hatzaras I, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery. 2013;153(6):811\u20138.","journal-title":"Surgery"},{"issue":"1","key":"4509_CR2","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"4509_CR3","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","volume":"21","author":"SK Saha","year":"2016","unstructured":"Saha SK, Zhu AX, Fuchs CS, Brooks GA. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise. Oncologist. 2016;21(5):594\u20139.","journal-title":"Oncologist"},{"key":"4509_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12876-016-0527-z","volume":"16","author":"KJ Yao","year":"2016","unstructured":"Yao KJ, Jabbour S, Parekh N, Lin Y, Moss RA. Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database. BMC Gastroenterol. 2016;16:117.","journal-title":"BMC Gastroenterol"},{"key":"4509_CR5","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol. 2023;79(1):181\u2013208.","DOI":"10.1016\/j.jhep.2023.09.006"},{"key":"4509_CR6","doi-asserted-by":"crossref","unstructured":"Meng ZW, Pan W, Hong HJ, Chen JZ, Chen YL. Macroscopic types of intrahepatic cholangiocarcinoma and the eighth edition of AJCC\/UICC TNM staging system. Oncotarget. 2017;8(60):101165\u201374.","DOI":"10.18632\/oncotarget.20932"},{"issue":"4","key":"4509_CR7","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/hep.30289","volume":"69","author":"AE Sirica","year":"2019","unstructured":"Sirica AE, Gores GJ, Groopman JD, Selaru FM, Strazzabosco M, Wang XW, et al. Intrahepatic cholangiocarcinoma: continuing challenges and translational advances. Hepatology. 2019;69(4):1803\u201315.","journal-title":"Hepatology"},{"issue":"11","key":"4509_CR8","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1111\/jgh.15593","volume":"36","author":"SY Ho","year":"2021","unstructured":"Ho SY, Liu PH, Hsu CY, Ko CC, Huang YH, Su CW, et al. Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. J Gastroenterol Hepatol. 2021;36(11):3196\u2013203.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"4509_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/SLA.0000000000002064","volume":"267","author":"K Sasaki","year":"2018","unstructured":"Sasaki K, Morioka D, Conci S, Margonis GA, Sawada Y, Ruzzenente A, et al. The tumor burden score: a new \u201cmetro-ticket\u2019\u2019 prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg. 2018;267(1):132\u201341.","journal-title":"Ann Surg"},{"issue":"7","key":"4509_CR10","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s00432-020-03200-2","volume":"146","author":"F Hahn","year":"2020","unstructured":"Hahn F, M\u00fcller L, Jungmann F, M\u00e4hringer-Kunz A, Tanyildizi Y, D\u00fcber C, et al. Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19\u20139 with cross-sectional imaging. J Cancer Res Clin Oncol. 2020;146(7):1883\u201390.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"4509_CR11","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s00261-023-03991-1","volume":"48","author":"J Kolck","year":"2023","unstructured":"Kolck J, Auer TA, Walter-Rittel T, Hosse C, Elkilany A, Marth AA, et al. Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it\u2019s not all about size. Abdom Radiol (NY). 2023;48(10):3063\u201371.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"4509_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archsurg.2011.771","volume":"147","author":"G Nuzzo","year":"2012","unstructured":"Nuzzo G, Giuliante F, Ardito F, Giovannini I, Aldrighetti L, Belli G, et al. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg. 2012;147(1):26\u201334.","journal-title":"Arch Surg"},{"issue":"5","key":"4509_CR13","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1148\/rg.285075183","volume":"28","author":"NI Sainani","year":"2008","unstructured":"Sainani NI, Catalano OA, Holalkere NS, Zhu AX, Hahn PF, Sahani DV. Cholangiocarcinoma: current and novel imaging techniques. Radiographics. 2008;28(5):1263\u201387.","journal-title":"Radiographics"},{"issue":"5","key":"4509_CR14","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s11605-020-04720-5","volume":"25","author":"DI Tsilimigras","year":"2021","unstructured":"Tsilimigras DI, Sahara K, Paredes AZ, Moro A, Mehta R, Moris D, et al. Predicting lymph node metastasis in intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2021;25(5):1156\u201363.","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"4509_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/hpb.12441","volume":"17","author":"SM Weber","year":"2015","unstructured":"Weber SM, Ribero D, O\u2019Reilly EM, Kokudo N, Miyazaki M, Pawlik TM. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford). 2015;17(8):669\u201380.","journal-title":"HPB (Oxford)"},{"key":"4509_CR16","doi-asserted-by":"publisher","first-page":"659422","DOI":"10.3389\/fsurg.2021.659422","volume":"8","author":"C Yuan","year":"2021","unstructured":"Yuan C, Hu Z, Wang K, Zou S. Development and validation a nomogram for predicting overall survival in patients with intrahepatic cholangiocarcinoma. Front Surg. 2021;8:659422.","journal-title":"Front Surg"},{"issue":"1","key":"4509_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","volume":"12","author":"MJ Hayat","year":"2007","unstructured":"Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007;12(1):20\u201337.","journal-title":"Oncologist"},{"issue":"3","key":"4509_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jclinepi.2014.06.018","volume":"68","author":"TPA Debray","year":"2015","unstructured":"Debray TPA, Vergouwe Y, Koffijberg H, Nieboer D, Steyerberg EW, Moons KGM. A new framework to enhance the interpretation of external validation studies of clinical prediction models. J Clin Epidemiol. 2015;68(3):279\u201389.","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"4509_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/heartjnl-2011-301247","volume":"98","author":"KGM Moons","year":"2012","unstructured":"Moons KGM, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: II. external validation, model updating, and impact assessment. Heart. 2012;98(9):691\u20138.","journal-title":"Heart"},{"issue":"5","key":"4509_CR20","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jamasurg.2013.5168","volume":"149","author":"O Hyder","year":"2014","unstructured":"Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer TW, et al. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg. 2014;149(5):432\u20138.","journal-title":"JAMA Surg"},{"key":"4509_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fonc.2011.00042","volume":"1","author":"YX Chen","year":"2011","unstructured":"Chen YX, Zeng ZC, Tang ZY, Fan J, Zhou J, Jiang W, et al. Prediction of the lymph node status in patients with intrahepatic cholangiocarcinoma: analysis of 320 surgical cases. Front Oncol. 2011;1:42.","journal-title":"Front Oncol"},{"issue":"7","key":"4509_CR22","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s11605-015-2803-6","volume":"19","author":"S Hwang","year":"2015","unstructured":"Hwang S, Lee YJ, Song GW, Park KM, Kim KH, Ahn CS, et al. Prognostic impact of tumor growth type on 7th AJCC staging system for intrahepatic cholangiocarcinoma: a single-center experience of 659 cases. J Gastrointest Surg. 2015;19(7):1291\u2013304.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"4509_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12876-024-03223-w","volume":"24","author":"H Xie","year":"2024","unstructured":"Xie H, Hong T, Liu W, Jia X, Wang L, Zhang H, et al. Interpretable machine learning-based clinical prediction model for predicting lymph node metastasis in patients with intrahepatic cholangiocarcinoma. BMC Gastroenterol. 2024;24(1):137.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"4509_CR24","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u201380.","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"4509_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","volume":"39","author":"SA Khan","year":"2019","unstructured":"Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: epidemiology and risk factors. Liver Int. 2019;39(Suppl 1):19\u201331.","journal-title":"Liver Int"},{"issue":"2","key":"4509_CR26","first-page":"198","volume":"73","author":"D Moris","year":"2022","unstructured":"Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin. 2022;73(2):198\u2013222.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"4509_CR27","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268\u201389.","journal-title":"J Hepatol"},{"key":"4509_CR28","doi-asserted-by":"publisher","first-page":"e074819","DOI":"10.1136\/bmj-2023-074819","volume":"384","author":"GS Collins","year":"2024","unstructured":"Collins GS, Dhiman P, Ma J, Schlussel MM, Archer L, Van Calster B, et al. Evaluation of clinical prediction models (part 1): from development to external validation. BMJ. 2024;384:e074819.","journal-title":"BMJ"},{"issue":"11","key":"4509_CR29","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/cncr.32803","volume":"126","author":"AA Florio","year":"2020","unstructured":"Florio AA, Ferlay J, Znaor A, Ruggieri D, Alvarez CS, Laversanne M, et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 2020;126(11):2666\u201378.","journal-title":"Cancer"},{"issue":"6","key":"4509_CR30","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","volume":"37","author":"SA Khan","year":"2002","unstructured":"Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002;37(6):806\u201313.","journal-title":"J Hepatol"},{"issue":"13","key":"4509_CR31","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/cncr.33476","volume":"127","author":"G Ouyang","year":"2021","unstructured":"Ouyang G, Liu Q, Wu Y, Liu Z, Lu W, Li S, et al. The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017. Cancer. 2021;127(13):2238\u201350.","journal-title":"Cancer"},{"issue":"1","key":"4509_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12885-019-5420-z","volume":"19","author":"M Sha","year":"2019","unstructured":"Sha M, Jeong S, Wang X, Tong Y, Cao J, Sun HY, et al. Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma. BMC Cancer. 2019;19(1):208.","journal-title":"BMC Cancer"},{"issue":"1","key":"4509_CR33","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1038\/s41598-021-83149-5","volume":"11","author":"TH Yu","year":"2021","unstructured":"Yu TH, Chen X, Zhang XH, Zhang EC, Sun CX. Clinicopathological characteristics and prognostic factors for intrahepatic cholangiocarcinoma: a population-based study. Sci Rep. 2021;11(1):3990.","journal-title":"Sci Rep"},{"issue":"3","key":"4509_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/MOG.0b013e328337c899","volume":"26","author":"H Nathan","year":"2010","unstructured":"Nathan H, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol. 2010;26(3):269\u201373.","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"4509_CR35","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s12877-024-05154-3","volume":"24","author":"J Shen","year":"2024","unstructured":"Shen J, Yang D, Zhou Y, Pei J, Wu Z, Wang X, et al. Development of machine learning models for patients in the high intrahepatic cholangiocarcinoma incidence age group. BMC Geriatr. 2024;24(1):553.","journal-title":"BMC Geriatr"},{"issue":"1","key":"4509_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000479929","volume":"94","author":"G Frega","year":"2018","unstructured":"Frega G, Garajov\u00e1 I, Palloni A, Barbera MA, Trossello Pastore M, Faccioli L, et al. Brain metastases from biliary tract cancer: a monocentric retrospective analysis of 450 patients. Oncology. 2018;94(1):7\u201311.","journal-title":"Oncology"},{"key":"4509_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7195373","volume":"2020","author":"F Hahn","year":"2020","unstructured":"Hahn F, M\u00fcller L, M\u00e4hringer-Kunz A, Tanyildizi Y, Santos DP, D\u00fcber C, et al. Distant metastases in patients with intrahepatic cholangiocarcinoma: does location matter? a retrospective analysis of 370 patients. J Oncol. 2020;2020:1\u20138.","journal-title":"J Oncol"},{"issue":"5","key":"4509_CR38","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","volume":"76","author":"L Izquierdo-Sanchez","year":"2022","unstructured":"Izquierdo-Sanchez L, Lamarca A, La Casta A, Buettner S, Utpatel K, Kl\u00fcmpen HJ, et al. Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry. J Hepatol. 2022;76(5):1109\u201321.","journal-title":"J Hepatol"},{"issue":"5","key":"4509_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.21037\/cco.2018.07.03","volume":"7","author":"AJ Lee","year":"2018","unstructured":"Lee AJ, Chun YS. Intrahepatic cholangiocarcinoma: the AJCC\/UICC 8th edition updates. Chin Clin Oncol. 2018;7(5):52.","journal-title":"Chin Clin Oncol"},{"issue":"11","key":"4509_CR40","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1007\/s00535-018-1469-8","volume":"53","author":"T Orimo","year":"2018","unstructured":"Orimo T, Kamiyama T, Mitsuhashi T, Kamachi H, Yokoo H, Wakayama K, et al. Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma. J Gastroenterol. 2018;53(11):1206\u201315.","journal-title":"J Gastroenterol"},{"issue":"2","key":"4509_CR41","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1245\/s10434-007-9687-y","volume":"15","author":"T Sano","year":"2007","unstructured":"Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Ann Surg Oncol. 2007;15(2):590\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"4509_CR42","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.soc.2019.06.002","volume":"28","author":"R El-Diwany","year":"2019","unstructured":"El-Diwany R, Pawlik TM, Ejaz A. Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am. 2019;28(4):587\u201399.","journal-title":"Surg Oncol Clin N Am"},{"issue":"6","key":"4509_CR43","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","volume":"149","author":"MN Mavros","year":"2014","unstructured":"Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma. JAMA Surg. 2014;149(6):565\u201374.","journal-title":"JAMA Surg"},{"issue":"2","key":"4509_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","volume":"72","author":"RK Kelley","year":"2020","unstructured":"Kelley RK, Bridgewater J, Gores GJ, Zhu AX. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72(2):353\u201363.","journal-title":"J Hepatol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04509-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:03:22Z","timestamp":1792422202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04509-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4509"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04509-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used de-identified data from the SEER database, which are publicly accessible after registration and completion of the SEER Research Data Agreement. Therefore, formal institutional review board approval and informed consent were not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The study used anonymized data from a public database. No individual personal data (including images, videos, or identifiable case details) is included in this article.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"403"}}